EssilorLuxottica Supports New WSPOS Independent Medical Education Program on Myopia Management

EssilorLuxottica announced it is supporting the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) independent medical education program on myopia management, as a gold level supporter, which will be launched on November 19 and 20, at 2-4pm GMT.

The key goals of this program are to raise awareness of myopia, discuss underlying causes and longterm impact on quality of life, examine current and evolving strategies to slow myopia progression in children, and define strategies to successfully integrate myopia management into practice for eye care practitioners. The program ‘Comprehensive update on myopia management’ is a 4-hour virtual interactive live symposium for eye care practitioners, where worldwide leading faculty will review the latest WSPOS myopia management guidelines, discuss how to navigate the latest treatment options, and share advice on how to best manage patients inside and outside of practice. The program will continue early next year with a digital supplement, three e-learning modules and three 60-minute webinars to continue this important education curriculum. Outcomes of learners will also be assessed to address the impact of the education on clinical opinions and practice patterns.

Eye care practitioners can register for the program here.

“We are very pleased to continue our partnership with WSPOS with this important program, and support its efforts to contribute to better vision for children. Through such programs, we look forward to supporting education to eye care practitioners to help them achieve better outcomes for their patients, in line with our mission to help people see more and be more," said Olga Prenat, Head of Medical Marketing, Professional Relations and Vision Care Education, EssilorLuxottica. "We encourage all eye care practitioners to participate in the program and will work together to continue to strengthen awareness and education on myopia and enhance access to available solutions to manage myopia worldwide.”